about
Identification of Nash1, a novel protein containing a nuclear localization signal, a sterile alpha motif, and an SH3 domain preferentially expressed in mast cellsInduction of RANTES by TWEAK/Fn14 interaction in human keratinocytesAnalysis of PU.1/ICSBP (IRF-8) complex formation with various PU.1 mutants: molecular cloning of rat Icsbp (Irf-8) cDNADisrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitment.IL-33 promotes MHC class II expression in murine mast cells.Notch signaling enhances FcεRI-mediated cytokine production by mast cells through direct and indirect mechanisms.Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.Transcriptional regulation of ATP2C1 gene by Sp1 and YY1 and reduced function of its promoter in Hailey-Hailey disease keratinocytes.Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.Involvement of PU.1 in the transcriptional regulation of TNF-alpha.Inhibitory effect of honeybee-collected pollen on mast cell degranulation in vivo and in vitro.Inhibitory effect of polyphenol-enriched apple extracts on mast cell degranulation in vitro targeting the binding between IgE and FcepsilonRI.The CD300e molecule in mice is an immune-activating receptor.Role of the ceramide-CD300f interaction in gram-negative bacterial skin infections.Involvement of PU.1 in NFATc1 promoter function in osteoclast development.Notch signaling confers antigen-presenting cell functions on mast cells.The Transcription Factor Ehf Is Involved in TGF-β-Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells.Cyclooxygenase-2 inhibition restores ultraviolet B-induced downregulation of ATP2A2/SERCA2 in keratinocytes: possible therapeutic approach of cyclooxygenase-2 inhibition for treatment of Darier disease.Suppressive effects of transcription factor GATA-1 on cell type-specific gene expression in dendritic cells.Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma.Leukocyte mono-immunoglobulin-like receptor 8 (LMIR8)/CLM-6 is an FcRγ-coupled receptor selectively expressed in mouse tissue plasmacytoid dendritic cells.Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activationExpression of phosphorylated Smad2 in normal human epidermisFormation of 8,11,14-octadecatrienoic acid (18:3 n-4) from naturally occurring unique fatty acid, 9,12-hexadecadienoic acid (16:2 n-4), in animal cell culturesAntimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokinesInvolvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infectionsHuman umbilical cord epithelial cells express Notch1: implications for its epidermal-like differentiationSuppressive effect of Elf-1 on FcepsilonRI alpha-chain expression in primary mast cellsGATA-1 is required for expression of Fc{epsilon}RI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrowRole of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cellsCritical role of transcription factor PU.1 in the expression of CD80 and CD86 on dendritic cellsFcepsilonRIalpha gene -18483A>C polymorphism affects transcriptional activity through YY1 bindingInteraction of functional FCER2 promoter polymorphism and phenotype-associated haplotypesStem cell factor suppressed IL-33-induced MHC class II expression in murine bone marrow-derived mast cellsCD300f is a potential therapeutic target for the treatment of food allergyDifferential Lipid Recognition by Mouse versus Human CD300f, Inhibiting Passive Cutaneous Anaphylaxis, Depends on a Single Amino Acid Substitution in its Immunoglobulin-Like Domain
P50
Q24291778-655D1ABB-FAE9-4E42-8246-951D3CB8CDAEQ28261447-1F55FF11-DA38-4796-AD9D-93CFF64A88ACQ28571247-335357BE-C765-47D6-835C-44E79D8D614BQ33842942-AACE9E80-79F1-4BD9-90AA-74A3CC72E81AQ36082314-BDF7D8E2-9F75-4D06-8176-761DB504B30CQ38893380-9B45E75B-4609-407C-9A37-517A49A4FC78Q39014475-6F793079-B6A1-42B5-84A8-3D3A788DC080Q40410135-F9669DF2-3417-4C49-8904-3C1E73E2140BQ41882434-7A5D4C01-69B8-4BEE-B11A-AED62D8B0538Q42006966-0099FB4A-9318-43D4-A279-B3F596C16583Q46562517-A25BA457-0FB9-43F3-8979-FF6E1BB47C5AQ46686434-1C327452-2177-48F6-86B4-9A13A2858FBDQ46770089-7CF278C6-E352-4781-9DA5-828CAB599A7CQ49874464-2AD47455-ECE2-4F4E-B898-E23AF230AD52Q49994183-BAA0C357-9BAD-49C8-8959-C6A4A630E0DDQ51488872-ABE42A04-A7BB-4123-985A-5BEC00242DEEQ51782619-E7AF33EB-9012-48E9-88E8-5F7CA5C76055Q53677174-6C07E4DD-1612-4EA7-88BB-9499D623F07EQ54319529-3BF9B4CC-0C57-454B-AD11-26313E301C7FQ54431749-60743057-DCC6-4CB9-9898-7BFCA81F8E68Q54741091-EFA3C330-68B9-4A03-BA2C-2AA3CDB6EF5AQ55208863-0AB9150D-E506-439C-83CB-390E659F6507Q58582001-660E685D-6444-43DB-BDA2-160C05A17659Q75390689-B8163F45-89D0-4574-B1DD-F08909ED0C72Q78137954-57CD8FD4-A8D9-438F-9E9C-6C32E0B2A781Q79306603-67407C6E-93CC-4C06-9A7F-98EAE537C2AEQ79749968-6DFEDC84-11B0-4DE5-9987-AE49A1AF4724Q81240122-ACE3F89D-0707-40A0-B9FE-FC5D2EC50D19Q81646148-F8491E14-C994-40AB-A85D-9DC434D06123Q81871558-C8F77D21-84DC-4467-99CB-2159278B1C06Q82656975-F86F2EB1-A405-4D88-9FCA-37246EB9022DQ82674317-DA4197B7-F4DA-49B0-A101-ECE423F6A4F6Q84414459-54262EBC-426D-40F5-9481-F3B3423832BDQ84759412-96641AD3-E4D4-4B10-ABFF-0F2CD4A10730Q91698078-D0E5D75C-5AFC-41E3-A92B-66D0D118D185Q93026858-1AD40DAD-24F5-4452-ACC4-8F59EBB00FEDQ93055875-EF58DEB3-AEE2-4B46-8330-61EDCD29E850
P50
description
researcher
@en
name
Nakano N
@nl
Nobuhiro Nakano
@en
type
label
Nakano N
@nl
Nobuhiro Nakano
@en
altLabel
Nakano N
@en
prefLabel
Nakano N
@nl
Nobuhiro Nakano
@en
P106
P31
P496
0000-0002-5317-5950